CCR5 and HIV-1 infection: The most investigated variation is the 32-bp deletion in the chemokine receptor-5 (CCR5 Δ32) gene, which was shown to confer resistance to HIV-1 infection in homozygous carriers, and its role has been investigated in a clinical context [8], [9].